Home Research COVID-19 Services Publications People Teaching Job Opening News Forum --> -->
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

BioLiP
Download all results in tab-seperated text for 65 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.

    • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)     		Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 6pnj:G (3.19) BS45 CLA 1.97.1.12 GO:0000287 ... G6FME9 N/A
    2 6pnj:G (3.19) BS46 CLA 1.97.1.12 GO:0000287 ... G6FME9 N/A
    3 6pnj:G (3.19) BS47 CLA 1.97.1.12 GO:0000287 ... G6FME9 N/A
    4 6pnj:G (3.19) BS48 CLA 1.97.1.12 GO:0000287 ... G6FME9 N/A
    5 6pnj:G (3.19) BS49 CLA 1.97.1.12 GO:0000287 ... G6FME9 N/A
    6 6pnj:H (3.19) BS01 peptide 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    7 6pnj:H (3.19) BS02 CL0 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    8 6pnj:H (3.19) BS03 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    9 6pnj:H (3.19) BS04 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    10 6pnj:H (3.19) BS05 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    11 6pnj:H (3.19) BS06 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    12 6pnj:H (3.19) BS07 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    13 6pnj:H (3.19) BS08 SF4 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    14 6pnj:H (3.19) BS09 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    15 6pnj:H (3.19) BS10 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    16 6pnj:H (3.19) BS11 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    17 6pnj:H (3.19) BS12 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    18 6pnj:H (3.19) BS13 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    19 6pnj:H (3.19) BS14 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    20 6pnj:H (3.19) BS15 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    21 6pnj:H (3.19) BS16 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    22 6pnj:H (3.19) BS17 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    23 6pnj:H (3.19) BS18 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    24 6pnj:H (3.19) BS19 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    25 6pnj:H (3.19) BS20 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    26 6pnj:H (3.19) BS21 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    27 6pnj:H (3.19) BS22 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    28 6pnj:H (3.19) BS23 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    29 6pnj:H (3.19) BS24 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    30 6pnj:H (3.19) BS25 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    31 6pnj:H (3.19) BS26 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    32 6pnj:H (3.19) BS27 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    33 6pnj:H (3.19) BS28 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    34 6pnj:H (3.19) BS29 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    35 6pnj:H (3.19) BS30 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    36 6pnj:H (3.19) BS31 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    37 6pnj:H (3.19) BS32 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    38 6pnj:H (3.19) BS33 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    39 6pnj:H (3.19) BS34 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    40 6pnj:H (3.19) BS35 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    41 6pnj:H (3.19) BS36 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    42 6pnj:H (3.19) BS37 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    43 6pnj:H (3.19) BS38 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    44 6pnj:H (3.19) BS39 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    45 6pnj:H (3.19) BS40 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    46 6pnj:H (3.19) BS41 F6C 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    47 6pnj:H (3.19) BS42 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    48 6pnj:H (3.19) BS43 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    49 6pnj:H (3.19) BS44 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    50 6pnj:H (3.19) BS45 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    51 6pnj:H (3.19) BS46 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    52 6pnj:H (3.19) BS47 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    53 6pnj:H (3.19) BS48 F6C 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    54 6pnj:H (3.19) BS49 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    55 6pnj:H (3.19) BS50 CLA 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    56 6pnj:H (3.19) BS51 PQN 1.97.1.12 GO:0000287 ... G6FMF0 N/A
    57 6pnj:Q (3.19) BS03 CLA ? GO:0009522 ... G6FMD3 N/A
    58 6pnj:R (3.19) BS01 CLA N/A GO:0009522 ... N/A N/A
    59 6pnj:R (3.19) BS02 CLA N/A GO:0009522 ... N/A N/A
    60 6pnj:S (3.19) BS02 F6C ? GO:0009522 ... G6FMD2 N/A
    61 6pnj:U (3.19) BS05 CLA ? GO:0009522 ... G6FMF1 N/A
    62 6pnj:U (3.19) BS06 CLA ? GO:0009522 ... G6FMF1 N/A
    63 6pnj:V (3.19) BS01 CLA ? GO:0009522 ... G6FWT6 N/A
    64 6pnj:V (3.19) BS02 CLA ? GO:0009522 ... G6FWT6 N/A
    65 6pnj:l (3.19) BS01 CLA ? GO:0009522 ... G6FMF1 N/A
    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).

    • yangzhanglabumich.edu | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218